Abstract

Transplantation of pancreatic islet cells derived from human pluripotent stem cells is a promising treatment for diabetes. Despite progress in the generation of stem-cell-derived islets (SC-islets), no detailed characterization of their functional properties has been conducted. Here, we generated functionally mature SC-islets using an optimized protocol and benchmarked them comprehensively against primary adult islets. Biphasic glucose-stimulated insulin secretion developed during in vitro maturation, associated with cytoarchitectural reorganization and the increasing presence of alpha cells. Electrophysiology, signaling and exocytosis of SC-islets were similar to those of adult islets. Glucose-responsive insulin secretion was achieved despite differences in glycolytic and mitochondrial glucose metabolism. Single-cell transcriptomics of SC-islets in vitro and throughout 6 months of engraftment in mice revealed a continuous maturation trajectory culminating in a transcriptional landscape closely resembling that of primary islets. Our thorough evaluation of SC-islet maturation highlights their advanced degree of functionality and supports their use in further efforts to understand and combat diabetes.

Pancreatic islets derived from stem cells are benchmarked against primary cells.

Details

Title
Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells
Author
Balboa, Diego 1   VIAFID ORCID Logo  ; Barsby, Tom 2 ; Lithovius, Väinö 2   VIAFID ORCID Logo  ; Saarimäki-Vire, Jonna 2   VIAFID ORCID Logo  ; Omar-Hmeadi, Muhmmad 3   VIAFID ORCID Logo  ; Dyachok, Oleg 3 ; Montaser, Hossam 2 ; Lund, Per-Eric 3 ; Yang, Mingyu 3   VIAFID ORCID Logo  ; Ibrahim, Hazem 2   VIAFID ORCID Logo  ; Näätänen, Anna 2 ; Chandra, Vikash 2   VIAFID ORCID Logo  ; Vihinen, Helena 4   VIAFID ORCID Logo  ; Jokitalo, Eija 4   VIAFID ORCID Logo  ; Kvist, Jouni 2 ; Ustinov, Jarkko 2 ; Nieminen, Anni I. 5   VIAFID ORCID Logo  ; Kuuluvainen, Emilia 6 ; Hietakangas, Ville 7 ; Katajisto, Pekka 8   VIAFID ORCID Logo  ; Lau, Joey 3   VIAFID ORCID Logo  ; Carlsson, Per-Ola 3 ; Barg, Sebastian 3 ; Tengholm, Anders 3   VIAFID ORCID Logo  ; Otonkoski, Timo 9   VIAFID ORCID Logo 

 University of Helsinki, Stem Cells and Metabolism Research Program, Faculty of Medicine, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Bioinformatics and Genomics Program, Barcelona, Spain (GRID:grid.11478.3b) (ISNI:0000 0004 1766 3695); Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain (GRID:grid.430579.c) (ISNI:0000 0004 5930 4623) 
 University of Helsinki, Stem Cells and Metabolism Research Program, Faculty of Medicine, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 Uppsala University, Department of Medical Cell Biology, Uppsala, Sweden (GRID:grid.8993.b) (ISNI:0000 0004 1936 9457) 
 University of Helsinki, Electron Microscopy Unit, Institute of Biotechnology, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 Institute for Molecular Medicine Finland, Metabolomics Unit, Helsinki, Finland (GRID:grid.452494.a) (ISNI:0000 0004 0409 5350) 
 University of Helsinki, Institute of Biotechnology, Helsinki Institute of Life Science, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 University of Helsinki, Institute of Biotechnology, Helsinki Institute of Life Science, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); University of Helsinki, Molecular and Integrative Bioscience Research Program, Faculty of Biological and Environmental Sciences, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 University of Helsinki, Institute of Biotechnology, Helsinki Institute of Life Science, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Karolinska Institutet, Department of Cell and Molecular Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 University of Helsinki, Stem Cells and Metabolism Research Program, Faculty of Medicine, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Helsinki University Hospital and University of Helsinki, Children’s Hospital, Helsinki, Finland (GRID:grid.15485.3d) (ISNI:0000 0000 9950 5666) 
Pages
1042-1055
Publication year
2022
Publication date
Jul 2022
Publisher
Nature Publishing Group
ISSN
10870156
e-ISSN
15461696
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2690033413
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.